TWD 13.85
(-0.72%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 28.94 Million TWD | -6.77% |
2022 | 31.04 Million TWD | -13.62% |
2021 | 35.94 Million TWD | 40.07% |
2020 | 25.65 Million TWD | -1.24% |
2019 | 25.98 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 24.13 Million TWD | -16.62% |
2024 Q2 | 24.13 Million TWD | 0.0% |
2023 FY | 28.94 Million TWD | -6.77% |
2023 Q2 | 30.56 Million TWD | 0.0% |
2023 Q1 | 30.56 Million TWD | -1.54% |
2023 Q3 | 28.94 Million TWD | -5.31% |
2023 Q4 | 28.94 Million TWD | 0.0% |
2022 Q3 | 31.04 Million TWD | 0.0% |
2022 Q4 | 31.04 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 95.188% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 81.379% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | 31.365% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 97.359% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 98.189% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 97.359% |
Center Laboratories, Inc. | 269.22 Million TWD | 89.249% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | 61.813% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 87.629% |
InnoPharmax Inc. | 22.24 Million TWD | -30.126% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 79.148% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 86.679% |
DV Biomed Co., Ltd. | 96.51 Million TWD | 70.011% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 77.173% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 89.803% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | 74.991% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -187.314% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | 48.268% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | 75.553% |